The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Bulk Drug-Global Market Insights and Sales Trends 2025

Bulk Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1827729

No of Pages : 125

Ask Your Query
Synopsis
The global Bulk Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bulk Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Bulk Drug market. Antibiotics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sulpha Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bulk Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bulk Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bulk Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bulk Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bulk Drug covered in this report include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche and Aurobindo pharma, etc.
The global Bulk Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Global Bulk Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bulk Drug market, Segment by Type:
Antibiotics
Sulpha Drugs
Vitamins,
Steroids
Analgesics
Others
Global Bulk Drug market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bulk Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bulk Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Bulk Drug Market Overview
1.1 Bulk Drug Product Overview
1.2 Bulk Drug Market Segment by Type
1.2.1 Antibiotics
1.2.2 Sulpha Drugs
1.2.3 Vitamins,
1.2.4 Steroids
1.2.5 Analgesics
1.2.6 Others
1.3 Global Bulk Drug Market Size by Type
1.3.1 Global Bulk Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Bulk Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bulk Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bulk Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bulk Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bulk Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bulk Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bulk Drug Sales Breakdown by Type (2018-2023)
2 Global Bulk Drug Market Competition by Company
2.1 Global Top Players by Bulk Drug Sales (2018-2023)
2.2 Global Top Players by Bulk Drug Revenue (2018-2023)
2.3 Global Top Players by Bulk Drug Price (2018-2023)
2.4 Global Top Manufacturers Bulk Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bulk Drug Market Competitive Situation and Trends
2.5.1 Bulk Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bulk Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bulk Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Bulk Drug Market
2.8 Key Manufacturers Bulk Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bulk Drug Status and Outlook by Region
3.1 Global Bulk Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bulk Drug Historic Market Size by Region
3.2.1 Global Bulk Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Bulk Drug Sales in Value by Region (2018-2023)
3.2.3 Global Bulk Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bulk Drug Forecasted Market Size by Region
3.3.1 Global Bulk Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Bulk Drug Sales in Value by Region (2024-2029)
3.3.3 Global Bulk Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bulk Drug by Application
4.1 Bulk Drug Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Bulk Drug Market Size by Application
4.2.1 Global Bulk Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Bulk Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bulk Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bulk Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bulk Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bulk Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bulk Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bulk Drug Sales Breakdown by Application (2018-2023)
5 North America Bulk Drug by Country
5.1 North America Bulk Drug Historic Market Size by Country
5.1.1 North America Bulk Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bulk Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Bulk Drug Sales in Value by Country (2018-2023)
5.2 North America Bulk Drug Forecasted Market Size by Country
5.2.1 North America Bulk Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Bulk Drug Sales in Value by Country (2024-2029)
6 Europe Bulk Drug by Country
6.1 Europe Bulk Drug Historic Market Size by Country
6.1.1 Europe Bulk Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bulk Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Bulk Drug Sales in Value by Country (2018-2023)
6.2 Europe Bulk Drug Forecasted Market Size by Country
6.2.1 Europe Bulk Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Bulk Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Bulk Drug by Region
7.1 Asia-Pacific Bulk Drug Historic Market Size by Region
7.1.1 Asia-Pacific Bulk Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bulk Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bulk Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bulk Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Bulk Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bulk Drug Sales in Value by Region (2024-2029)
8 Latin America Bulk Drug by Country
8.1 Latin America Bulk Drug Historic Market Size by Country
8.1.1 Latin America Bulk Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bulk Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bulk Drug Sales in Value by Country (2018-2023)
8.2 Latin America Bulk Drug Forecasted Market Size by Country
8.2.1 Latin America Bulk Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bulk Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Bulk Drug by Country
9.1 Middle East and Africa Bulk Drug Historic Market Size by Country
9.1.1 Middle East and Africa Bulk Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bulk Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bulk Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bulk Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Bulk Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bulk Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Bulk Drug Products Offered
10.1.5 Teva Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Bulk Drug Products Offered
10.2.5 Novartis Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Bulk Drug Products Offered
10.3.5 Pfizer Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Bulk Drug Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Bulk Drug Products Offered
10.5.5 Mylan Recent Development
10.6 North China Pharmaceutical Group
10.6.1 North China Pharmaceutical Group Company Information
10.6.2 North China Pharmaceutical Group Introduction and Business Overview
10.6.3 North China Pharmaceutical Group Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 North China Pharmaceutical Group Bulk Drug Products Offered
10.6.5 North China Pharmaceutical Group Recent Development
10.7 Dr. Reddy’s Laboratories
10.7.1 Dr. Reddy’s Laboratories Company Information
10.7.2 Dr. Reddy’s Laboratories Introduction and Business Overview
10.7.3 Dr. Reddy’s Laboratories Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Dr. Reddy’s Laboratories Bulk Drug Products Offered
10.7.5 Dr. Reddy’s Laboratories Recent Development
10.8 Roche
10.8.1 Roche Company Information
10.8.2 Roche Introduction and Business Overview
10.8.3 Roche Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Roche Bulk Drug Products Offered
10.8.5 Roche Recent Development
10.9 Aurobindo pharma
10.9.1 Aurobindo pharma Company Information
10.9.2 Aurobindo pharma Introduction and Business Overview
10.9.3 Aurobindo pharma Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aurobindo pharma Bulk Drug Products Offered
10.9.5 Aurobindo pharma Recent Development
10.10 Sun Pharmaceutical Industries
10.10.1 Sun Pharmaceutical Industries Company Information
10.10.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.10.3 Sun Pharmaceutical Industries Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sun Pharmaceutical Industries Bulk Drug Products Offered
10.10.5 Sun Pharmaceutical Industries Recent Development
10.11 Boehringer Ingelheim GmbH
10.11.1 Boehringer Ingelheim GmbH Company Information
10.11.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.11.3 Boehringer Ingelheim GmbH Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer Ingelheim GmbH Bulk Drug Products Offered
10.11.5 Boehringer Ingelheim GmbH Recent Development
10.12 Bayer
10.12.1 Bayer Company Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bayer Bulk Drug Products Offered
10.12.5 Bayer Recent Development
10.13 BASF
10.13.1 BASF Company Information
10.13.2 BASF Introduction and Business Overview
10.13.3 BASF Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 BASF Bulk Drug Products Offered
10.13.5 BASF Recent Development
10.14 DSM
10.14.1 DSM Company Information
10.14.2 DSM Introduction and Business Overview
10.14.3 DSM Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 DSM Bulk Drug Products Offered
10.14.5 DSM Recent Development
10.15 Zhejiang Medicine
10.15.1 Zhejiang Medicine Company Information
10.15.2 Zhejiang Medicine Introduction and Business Overview
10.15.3 Zhejiang Medicine Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Zhejiang Medicine Bulk Drug Products Offered
10.15.5 Zhejiang Medicine Recent Development
10.16 Biocon
10.16.1 Biocon Company Information
10.16.2 Biocon Introduction and Business Overview
10.16.3 Biocon Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Biocon Bulk Drug Products Offered
10.16.5 Biocon Recent Development
10.17 Johnson Matthey
10.17.1 Johnson Matthey Company Information
10.17.2 Johnson Matthey Introduction and Business Overview
10.17.3 Johnson Matthey Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Johnson Matthey Bulk Drug Products Offered
10.17.5 Johnson Matthey Recent Development
10.18 Hisun Pharmacy
10.18.1 Hisun Pharmacy Company Information
10.18.2 Hisun Pharmacy Introduction and Business Overview
10.18.3 Hisun Pharmacy Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Hisun Pharmacy Bulk Drug Products Offered
10.18.5 Hisun Pharmacy Recent Development
10.19 Cambrex
10.19.1 Cambrex Company Information
10.19.2 Cambrex Introduction and Business Overview
10.19.3 Cambrex Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Cambrex Bulk Drug Products Offered
10.19.5 Cambrex Recent Development
10.20 Shandong Xinhua Pharmaceutical
10.20.1 Shandong Xinhua Pharmaceutical Company Information
10.20.2 Shandong Xinhua Pharmaceutical Introduction and Business Overview
10.20.3 Shandong Xinhua Pharmaceutical Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Shandong Xinhua Pharmaceutical Bulk Drug Products Offered
10.20.5 Shandong Xinhua Pharmaceutical Recent Development
10.21 Lonza group
10.21.1 Lonza group Company Information
10.21.2 Lonza group Introduction and Business Overview
10.21.3 Lonza group Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Lonza group Bulk Drug Products Offered
10.21.5 Lonza group Recent Development
10.22 Huahai Pharmaceutical
10.22.1 Huahai Pharmaceutical Company Information
10.22.2 Huahai Pharmaceutical Introduction and Business Overview
10.22.3 Huahai Pharmaceutical Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Huahai Pharmaceutical Bulk Drug Products Offered
10.22.5 Huahai Pharmaceutical Recent Development
10.23 Haerbin Pharmaceutical Group
10.23.1 Haerbin Pharmaceutical Group Company Information
10.23.2 Haerbin Pharmaceutical Group Introduction and Business Overview
10.23.3 Haerbin Pharmaceutical Group Bulk Drug Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Haerbin Pharmaceutical Group Bulk Drug Products Offered
10.23.5 Haerbin Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bulk Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bulk Drug Industrial Chain Analysis
11.4 Bulk Drug Market Dynamics
11.4.1 Bulk Drug Industry Trends
11.4.2 Bulk Drug Market Drivers
11.4.3 Bulk Drug Market Challenges
11.4.4 Bulk Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bulk Drug Distributors
12.3 Bulk Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock